ELAN_Trial Profile Banner
The ELAN Trial Profile
The ELAN Trial

@ELAN_Trial

Followers
478
Following
182
Media
0
Statuses
735

Official account of the #ELAN Trial.

Bern, Switzerland
Joined September 2020
Don't wanna be here? Send us removal request.
@sheilambrasil
sheila martins
1 day
Uma oportunidade única de aprender com quem está transformando o cuidado do AVC no mundo! 🔍 De 2 a 5 de dezembro, São Paulo será o ponto de encontro de especialistas internacionais no Latin America Stroke Summer School 2025. Temos um convite especial para você viver quatro
0
10
13
@ESOstroke
European Stroke Org
3 days
Great energy at the Mid-Career Poster Session at #ESSW! 20 impressive posters showcased cutting-edge research, sparked insightful discussions, and highlighted the strength of our growing community. A big success - and an exciting glimpse into the future of stroke science! 🧠✨
0
9
14
@ESOstroke
European Stroke Org
3 days
What an engaging way to start the European Stroke Science Workshop - with a keynote debate about IAT following MT or not and voting. We are looking forward to two days of exchange, discussions and networking. #ESSW @FishingNeurons #strokeeducation #stroketwitter
0
8
15
@ESOstroke
European Stroke Org
23 days
🧠You can still register for the #WSC2025 Highlights Webinar — hosted by ESO, @WorldStrokeOrg and @American_Stroke. Get key updates in stroke research & care. 🔗 https://t.co/Elo9Azcya4 #Stroke #StrokeScience #StrokeEducation #Neurology @SposatoL @eva_mistry @jeyaraj_pandian
0
13
29
@sheilambrasil
sheila martins
26 days
📣 Calling all stroke specialists in Latin America! Join us in São Paulo, Dec 2–5 2025, for the first Latin America Stroke Summer School from University of Bern in partnership with Rede Brasil AVC and ESO, endorsed by WSO. 🎥 Check out Urs Fischer’s invitation and get ready for
4
18
33
@ESOstroke
European Stroke Org
1 month
WSO-ESO joint session #WSC2025: @FishingNeurons presenting ESO initiatives to improve #strokecare with the clear call to include patients. „Only together we can achieve change.“ #stroke #strokesurvivor #StrokeActionPlan @StrokeEurope @WorldStrokeOrg
0
8
30
@ESOstroke
European Stroke Org
2 months
📢 From 1 Jan 2026, the European Stroke Journal will be published by Oxford University Press & become fully open access. Articles submitted will be OA under a Creative Commons license (APC applies). 👉 https://t.co/eQclQgXGZj #ESJ #Stroke #StrokeScience #OpenAccess #Neurology
1
5
18
@TECNO_Trial
The TECNO
3 months
🚨 TECNO trial update 🚨 131 patients enrolled! Only 25 more to hit our target of 156 - the final countdown is on 🏁 We sincerely thank all the centers and investigators on their efforts! 💪 #TECNO 💿
1
12
21
@StrokeSchool
StrokeWinterSchool
3 months
0
12
15
@DavidSeiffge
David Seiffge
3 months
@GreenJournal
Neurology Journal
3 months
Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #stroke in patients with #AtrialFibrillation. Listen now: https://t.co/5OrxanHR0D #NeuroTwitter @DrDanAckerman
0
8
14
@FishingNeurons
Urs Martin Fischer
3 months
Many thanks for the opportunity to discuss the CATALYST meta-analysis and our ongoing trials (ELAPSE and DO IT). @BoNorrving @SignildAsberg @DavidSeiffge @TotoMynell @unibern
@GreenJournal
Neurology Journal
3 months
Neurology Podcast: Dr. Dan Ackerman and Dr. Urs Fischer discuss the optimal timing of anticoagulation after ischemic #stroke in patients with #AtrialFibrillation. Listen now: https://t.co/5OrxanHR0D #NeuroTwitter @DrDanAckerman
0
18
42
@FishingNeurons
Urs Martin Fischer
3 months
I have been invited to talk about our CATALYST meta-analysis in the ‚Neurology Podcast‘. Press the button below and find out more on CATALYST, but also on our ELAPSE and DO IT trials. ⁦@BoNorrving⁩ ⁦@SignildAsberg⁩ ⁦@SeiffgeDavid
1
17
46
@ESOstroke
European Stroke Org
3 months
Mark your calendars now! 📅 Save the Date: 6-8 May 2026, #ESOC2026 in Maastricht We can't wait to bring you more details this autumn, so stay tuned for updates!🔗 https://t.co/kHnG0xZGup #Neurology #Stroke #VoiceOfStroke
0
10
17
@ESOstroke
European Stroke Org
3 months
Dr Costru-Tașnic reflects on her inspiring journey as part of the 2024–2026 European Stroke Master Programme in Bern, supported by an ESO scholarship. She brings fresh ideas to improve stroke care in Moldova. 🔗 https://t.co/bSGqfhIUtH 📣 Apply: https://t.co/QcjSIuPad3 #Stroke
0
8
10
@MASStroke
European Stroke Master
3 months
Do you want to become a Stroke Master? Apply for the European Stroke Master Study Programme (@MASStroke) until 31 August 2025. https://t.co/jEPPFieAMN
0
4
7
@IntJStroke
International Journal of Stroke
3 months
🧠Decompressive craniectomy ⬇️reduces mortality and ⬆️improves neurological function in selected spontaneous ICH patients vs best medical treatment alone Read more below!👇 https://t.co/4V7OQk0ri5
0
30
84
@FishingNeurons
Urs Martin Fischer
3 months
Does intravenous thrombolysis prior endovascular treatment (EVT) increases the risk of intracranial haemorhage compared to EVT alone? Check our latest article in JAMA Neurology! @StrokeBern @CheesemakerMD @fabianoca @kiliantreurniet @manonkappelhof @TotoMynell
@JAMANeuro
JAMA Neurology
3 months
Compared with endovascular treatment (EVT) alone, intravenous thrombolysis plus EVT modestly increased the risk of intracranial hemorrhage, notably any parenchymal hematoma. https://t.co/O0Biy9VKVU
0
20
44
@StrokeAHA_ASA
Stroke AHA/ASA
3 months
🌟 @ELAN_Trial subanalysis shows that prior reperfusion strategy does not modify outcome in early vs late start of anticoagulants in acute ischemic stroke patients. @TakeshiYoshimo4 @Yperzeele_L @TweetNeuroLine @rorohner @mbgoeldlin @FishingNeurons
1
9
12
@stephanamayer
Stephan A Mayer
3 months
The Upshot: When a patient with AF has a stroke on a DOAC, don’t switch to warfarin. The result will be a higher risk of recurrent stroke and ICH down the road Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on DOACs
neurology.org
Background and ObjectivesThe management of anticoagulation after ischemic stroke while on direct oral anticoagulants (DOACs) is controversial. We performed an aggregate-data meta-analysis to compare...
3
50
126